Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 702 citations
Electronic publication date
October 21, 2000

View on Pubmed.gov 11034215 | View on doi.org 10.1038/3503661...

Role for the p53 homologue p73 in E2F-1-induced apoptosis.

Search for publications in this journal Nature - 407(6804):645-8

Abstract

The transcription factor E2F-1 induces both cell-cycle progression and, in certain settings, apoptosis. E2F-1 uses both p53-dependent and p53-independent pathways to kill cells. The p53-dependent pathway involves the induction by E2F-1 of the human tumour-suppressor protein p14ARF, which neutralizes HDM2 (human homologue of MDM2) and thereby stabilizes the p53 protein. Here we show that E2F-1 induces the transcription of the p53 homologue p73. Disruption of p73 function inhibited E2F-1-induced apoptosis in p53-defective tumour cells and in p53-/- mouse embryo fibroblasts. We conclude that activation of p73 provides a means for E2F-1 to induce death in the absence of p53.

References

No references provided.

Cited by 702 citations (total)

Journal Article Research Support, Non-U.S. Gov't

E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.

Electronic publication date August 4, 2004

Search for publications in this journal J Virol

Urs Hobom [...] Matthias Dobbelstein et al.

The adenovirus E1B-55-kDa protein binds and inactivates the tumor suppressor protein p53. However, the role of this interaction during infection...

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation.

Electronic publication date June 18, 2004

Search for publications in this journal Mol Cell Biol

B Nelson Chau [...] Jean Y J Wang et al.

The retinoblastoma protein (RB) suppresses cell proliferation and apoptosis. We have previously shown that RB degradation is required for tumor...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances